BI 764532
Boehringer Ingelheim
['sclc']
bi764532 is a dll3/cd3 bite, ph1 in sclc or necs. crs mostly g1-2. lymphopenia g3 16%. 4% discont for aes. dose escalation ongoing. 18% orr across all doses. encouraged to see this data, although even low grade crs can be difficult to manage in ambulatory setting #asco23 
Thoracic Oncologist @royalmarsdenNHS, Professor @ICR_London; Chair @BTOGorg; views are my own.